What is Mckenna Abercrombie Dewees's NPI number?

Mckenna Abercrombie Dewees's National Provider Identifier (NPI) is 1902366008, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Mckenna Abercrombie Dewees's specialty?

Mckenna Abercrombie Dewees is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Mckenna Abercrombie Dewees located?

Mckenna Abercrombie Dewees's practice location on file with NPPES is 540 Medical Oaks Ave Ste 102, Brandon, FL 33511-5995.

What is Mckenna Abercrombie Dewees's phone number?

The practice phone number listed in the NPPES registry for Mckenna Abercrombie Dewees is (866) 400-3376.

Does Mckenna Abercrombie Dewees accept Medicare?

Mckenna Abercrombie Dewees is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Mckenna Abercrombie Dewees's NPI active?

Yes — Mckenna Abercrombie Dewees's NPI (1902366008) is active in the NPPES registry as of the last update on 2023-10-13.

IndividualActiveAccepts Medicare

Mckenna Abercrombie Dewees, DO

NPI 1902366008 · Dermatology Physician · Brandon, FL

Mckenna Abercrombie Dewees, DO is a Dermatology Physician provider in Brandon, FL (NPI 1902366008).

Provider details

NPI number: 1902366008
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: DO
Sex: Female
Sole proprietor: No
License: 20117 (FL)

Practice location

540 Medical Oaks Ave Ste 102

Brandon, FL 33511-5995

Phone: (866) 400-3376

Fax: (813) 651-1401

Street-level locationGet directions

More FL providers

Mailing address

151 Southhall Ln Ste 300

Maitland, FL 32751-7172

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 20117 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(55/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
7 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
526 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	153	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	98	$88
Destruction of Precancer Skin Growth, 1 Growth17000	56	$49
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	56	$109
Biopsy of Related Skin Growth, First Growth11102	38	$84
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	213	108
Clobetasol Propionate	140	87
Hydrocortisone	120	77
Triamcinolone Acetonide	112	79
Mupirocin	63	40
Minoxidil	40	18
Fluorouracil	36	30
Tretinoin	31	15

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,610 across 132 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2019-03-23
Last updated: 2023-10-13
Certified: 2023-10-13

Frequently asked questions

What is Mckenna Abercrombie Dewees's NPI number?: Mckenna Abercrombie Dewees's National Provider Identifier (NPI) is 1902366008, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Mckenna Abercrombie Dewees's specialty?: Mckenna Abercrombie Dewees is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Mckenna Abercrombie Dewees located?: Mckenna Abercrombie Dewees's practice location on file with NPPES is 540 Medical Oaks Ave Ste 102, Brandon, FL 33511-5995.
What is Mckenna Abercrombie Dewees's phone number?: The practice phone number listed in the NPPES registry for Mckenna Abercrombie Dewees is (866) 400-3376.
Does Mckenna Abercrombie Dewees accept Medicare?: Mckenna Abercrombie Dewees is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Mckenna Abercrombie Dewees's NPI active?: Yes — Mckenna Abercrombie Dewees's NPI (1902366008) is active in the NPPES registry as of the last update on 2023-10-13.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	153	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	98	$88
Destruction of Precancer Skin Growth, 1 Growth17000	56	$49
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	56	$109
Biopsy of Related Skin Growth, First Growth11102	38	$84
Destruction of Skin Growth, 1-14 Growths

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

213

108

Clobetasol Propionate

140

Hydrocortisone

120

Triamcinolone Acetonide

112

Mupirocin

Minoxidil

Fluorouracil

Tretinoin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,610 across 132 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments